Ulla Schwager
Lobbying Activity
Meeting with Johnson Johnson and
3 Dec 2025 · Exchange of views on developments in the pharmaceutical industry and aspects of competition law and policy enforcement in this industry sector
Meeting with MEDICINES FOR EUROPE
24 Nov 2025 · Discussion on the practical implications of the environmental risk assessment
Meeting with Eumicon AISBL
19 Nov 2025 · Competitive situation of the European raw materials sector
Meeting with Teva Pharmaceuticals Europe BV
10 Jul 2025 · Exchange of views on the pharmaceutical sector and on competition policy enforcement
Meeting with MEDICINES FOR EUROPE
3 Mar 2025 · Exchange of views on the future Critical Medicines Act
Meeting with MEDICINES FOR EUROPE
25 Feb 2025 · Exchange of views on Pharma & IP Legislation Reform & possible anti-competitive practices in the pharmaceutical sector